(listed alphabetically by last name – click on name for full profile)
San Francisco, United States
This is a unique moment to address the global burden of cancer. Political will is high, with the Sustainable Development Goals and the Noncommunicable Diseases targets rising to the top of the health agenda. And more than ever we are aware of the global inequities in cancer care, prevention, survivorship and palliative care within and between countries. As we increasingly understand the social determinants of health, we can advocate for a holistic approach in care and in policy. UICC is well positioned to play a significant role in informing the global cancer agenda. It is an exciting opportunity for people like me, who spent over 3 decades in cancer care and control, to engage as part of the UICC Board of Directors and bring a voice for nursing, for cancer prevention and for building health capacity and leadership. I am looking forward to support C/Can 2025 where I can add my experience working with multiple sectors of government in LMICs, particularly in Africa, Latina America and South East Asia.
UICC is continuing to evolve and innovate. I have the honour of having been recognized for my work by WHO and others, and to have the full support from my peers as I seek a role on the Board. Being on the Board of Directors will give myself, together with my fellow Board Members, and UICC team, the opportunity to contribute to bringing real and lasting change to ensure that cancer care and control is one that I would value tremendously and would commit to wholeheartedly.
I will add to the Board’s mix of experiences and skills. I was born, went to college and started working in Brazil. I also experienced education in the USA, where I now live. Studying and working in two very different settings gave me an appreciation for high standards of care and for providing evidence-based care with few resources. I have the honour of being part of international cancer nursing since 1991 through the International Society of Nurses in Cancer Care, most recently as its President (2014-18). I am committed to ensure that nurses, the largest group of healthcare professionals worldwide, and nursing organisations enhance their engagement in cancer care and control. Globally, most cancer patients do not have access to specialised nursing care.
Specialty care is a goal, but we need to ensure that nurses in various settings are prepared to care for cancer patients. I have decades of involvement in international tobacco control, especially the development and implementation of the WHO Framework Convention on Tobacco Control. I have worked with WHO and the Convention Secretariat since 1999, gaining a great experience in international health diplomacy, providing technical assistance to governments and all of WHO Regions. I remain committed to saving lives through tobacco control. My networking skills are facilitated by fluency in four languages. I will bring to the board a depth of knowledge and commitment to address the tobacco and cancer-global burden of disease.
Ever increasing rate of cancer especially among children around the world highlights deficiencies such as lack of expertise and facilities or inefficient policy making systems particularly in low and middle income countries, while NGOs have proved their invaluable impact on improving access to cancer diagnosis and treatment services.
Hence, more participatory approach to planning impactful approaches for advocacy to raise awareness, and implementing more applicable cancer control campaigns by considering other relevant factors like cultural norms and beliefs along with real infrastructural and capacity restrictions are required.
Having constructive access to 110 haematologist-oncologists around the country for the past decade as MAHAK CEO, I have contributed as core participatory actions to forging effective coalitions, developing equity-based organisational capacities, shaping public legitimacy, and bridging gaps between health care professionals, psycho-social support mechanisms, public policy makers, international agencies, and societal stakeholders. These experiences and traits are transferable to UICC, the forum for influencing paediatric cancer care globally.
Since childhood cancer has been neglected comparing to the attention given to cancers in adults, as a manager who is leading one of the best of its kind centres in the region I would take the lead in UICC to pay more attention to this issue in formulating and implementing child-centric cancer control policies.
Since 2008, I have been the CEO of MAHAK, the 26-year old Society to Support Children Suffering from Cancer in Iran where, as a non-medical expert managing one of the largest hospitals and charity organizations, I have acquired a great overview on formation of policies and actions in developing countries.
As the CEO, I have augmented the prestige of MAHAK in the international arena by advocating and planning a multidisciplinary treatment approach born from our extensive experience in paediatric cancer. I have also overseen our ongoing advisory role at ECOSOC and partnership with UNHCR.
As the chair of the B.o.D of Iranian National Network of Cancer, I have gathered 37 NGOs to effectively communicate with the Ministry of Health and Medical Education to have more impact on related policy developments in Iran.
Regarding resource mobilization, by developing sustainable resource supply system reliant exclusively on public sources, MAHAK’s income increased 23% from €53,000,000 in 2015 to €65,000,000 in 2016 achieving for the first time the capacity to cover 100% of the supportive and treatment expenses for children with cancer.
I believe my experiences and passion to promote comprehensive and integrated services for children with cancer and their families can contribute to UICC to identify new strategies for advocacy, raising awareness within the society and engaging stakeholders to create the best circumstances for our patients presently and for the foreseeable future.
My experience as a Clinician and a surgeon for 34 years, and a diplomat as an ambassador in the Foreign service responsible for Sub-Sahara Africa’s 44 countries and that I was also involved globally in senior positions in Asian and international Sports medicine boards and my work in Global Road Safety, also my work and experience with WHO Geneva and EMRO region I am driven to apply for the membership of the highly esteemed UICC Board of Directors.
As a husband of a 4 times cancer survivor and as one of the founder members of Oman Cancer Association (OCA) since 18 years ago, I believe and I am convinced that I will be active and have time to support UICC and the Cancer patients, their families, the communities at large and Healthcare providers both nationally and globally. I can support the LMIC as a board member more with the network I have of the International Cancer Prevention Consortium (ICPC). I believe with my background and global experience in Clinical work and diplomacy, I will not only serve UICC well, but I will make a difference and be effective in the promotion and advocacy of cancer prevention and control. I am convinced, comfortable and believe in the excellent, efficient and productive work UICC is doing and also the efficient organisational setup and will be an honour to serve as a board member of UICC as I know I will be productive.
Convinced with the excellent work and results of UICC, and my conviction that defeating cancers is in the concept of prevention and control especially in creation of awareness, human resource development, and research, and my commitment to performing what I believe in, I am sure that I will prove to be an excellent candidate for the board of UICC.
I am a professional, respectable, with a high sense of personal integrity, innovative, respect for diversity, with compassion and passion with what I am involved with.
My background as a clinician and as a diplomat with international connections together as a husband of a four times cancer survivor I am convinced I will be able to share my experiences. Hence my membership in the board will be effective in promoting the UICC policies, especially in the regions that are mostly affected and poorly addressing the cancer status.
My network and experience nationally and globally, especially with the ICPC (International Cancer Prevention Consortium) and with my relationship with all the stakeholders will support the building of a strong and a cohesive infrastructure for cancer prevention and control at all levels.
During my leadership at the Swedish Cancer Society one of my main focuses has been on addressing the unequal cancer care across Sweden. To bring awareness to this issue, we have successfully initiated broad discussions on this subject with decision makers and professionals alike. The political impact and equal cancer care are central to my involvement and areas I would like to continue to focus on within the framework of UICC. My wish is to contribute to the shaping of the vision and the strategy for UICC to meet and address current and future challenges. We need to advance the implementation of existing policies in order to meet the World Cancer Declaration Targets. UICC can, with its gained experience and insight into global cancer control, play a key role in the implementation of the cancer resolution from 2017, both on international and national levels. Additionally, we know that 30-50 % of all cancers can be prevented and UICC has a key role in reinforcing the importance of cancer prevention. Through learning and exchanging knowledge and experience with the Board members and colleagues within the UICC network, I hope to identify strategies that continue to make an impact on the global stage and establish equal cancer care. UICC and the Board of Directors have a crucial role in ensuring cancer’s place on the global health agenda and I would be honoured to be able to bring together the experiences from different member organisations to reduce the global cancer burden.
Since 2016 I have been the Secretary General of Cancerfonden, the largest fundraising organisation in Sweden. The core activity is financing research. As Sweden’s largest organisation in the field of cancer, we actively participate in the general debate about the disease and we play a strong advocacy role. For ten years, I worked for the Swedish Red Cross as Secretary General and previously as Deputy Secretary-General. It provided me with a comprehensive understanding of international work, collaboration and resource mobilisation through the Red Cross Red Crescent Movement. My previous role has given me extensive experience in negotiating with governments, financiers and member associations. I have participated in international work groups that covered capacity building, field reviews, global branding and strategy. Together with the Swedish government, I have driven the issue of Gender and International Humanitarian Law. Since 2017, I have been proud to be the chairman of the Royal Dramatic Theater, and previously as vice president at the Swedish National Theater. These opportunities has widened my perspectives and deepened my leadership skills in crisis and change management. My leadership style can be described as calm, open and with an ability to create commitment and stability. This together with my international experience forms a solid foundation to contribute to UICC's international work.
Washington DC, United States
I would like to be on the Board to contribute my experience in public policy and public health to fighting the global cancer battle. Where you live shouldn’t determine if you live! I know how to get things done to amplify cancer control advocacy messages and programme implementation both at country-level and above country level through living and working in Latin America, the Eastern Mediterranean and Asia and being the Director of External Relations at UNAIDS as the AIDS pandemic grew. Under my leadership, we got HIV AIDS prevention and control on the radar screen of policy makers around the world. We need to do the same for cancer, today a bigger burden of disease than AIDS, but one which is only marginally talk about and which lacks resources. Cancer in Africa is a more feared and more stigmatised disease than HIV. UICC can lead the fight to change this reality. I have spent the last two decades in key positions at leading civil society organisations such as the American Cancer Society. I would like to be on the Board to share the lessons of non-profit management from these organisations to make UICC the most powerful voice in the cancer world. To be successful in controlling the global cancer tsunami we need a powerful message and a good organisation. I would like to contribute to both.
During my first term on the UICC Board (2017-18) I have had an opportunity to serve on three key committees: Governance, Membership and the ad hoc steering committee on strategic planning. If re-elected to the next term I will be able to get right to work on the major challenges and opportunities to implementing the vision outlined for UICC in the new strategic plan, which I helped to develop. Continuity is also an issue at UICC as several board members are term-limited. I would serve as an experienced hand to assist the President and President-Elect in carrying out their mandate. Substantively, I can and will contribute to the UICC advocacy priorities such as the elimination of cervical cancer and treatment for all as the American Cancer Society senior executive responsible for ACS global work in these same areas. I am a member of the WHO expert committee on the implementation of the cancer resolution passed by the WHA in 2017.
I have 30 years experience in cancer control. A social and behavioural scientist, my leadership skills are evidenced by my effectiveness in bringing organisations together to reduce the burden of cancer on the community. I draw on a distinguished career as CEO of Cancer Council Queensland, current Board Member and Treasurer of UICC and have recently taken up the position of Professor and Chair of Social and Behavioural Sciences at the University of Southern Queensland. As a global advocate for patient-centred care my focus is the translation of epidemiological and psycho-oncological research into practice. International achievements include gaining endorsement from cancer control organisations worldwide for quality standards in psychosocial care. My commitment is to enable civil society to assist individuals, communities and health authorities to combat cancer. Relevant experience includes work with NGOs in LMICs to implement regionally-specific cancer control programs. I am Immediate-past President Asian Pacific Organization for Cancer Prevention and convened the first Asia-Pacific Cancer Leaders’ Summit with UICC; and in January 2018 with colleagues at UICC and Nepal convened the inaugural International Cancer Congress in that country. I have served as Chair Reach to International and Secretary of the International Psycho-oncology Society. If re-elected, I will continue to apply my experience, skills and influence to advocate for the World Cancer Declaration.
I have been working with UICC for 25 years and currently serve as Board member and Treasurer. Previously I have held numerous UICC positions including: Chair of the Asia Pacific Cancer Society Training Grants Program, Strategic Leader Capacity Building, Regional Coordinator Asia Pacific Region and Chair of Reach to Recovery International. In addition to leading social and behavioural science research at the University of Southern Queensland, I hold a Professorial appointment with Griffith University School of Medicine. I have a central focus on the social and behavioural aspects of cancer control, spanning the continuum of research from prevention and early detection to supportive care and quality of life. As an active researcher in this field I have dedicated my career to the development of novel strategies that underpin cancer prevention, promote community awareness of the disease and improve quality of life after a cancer diagnosis. My service to cancer control includes policy, programme development, advocacy and translation of research into community-based interventions. I am a Graduate of the Australian Institute of Company Directors and have extensive experience on national/state-based Boards and cancer-related advisory committees. I was appointed an Officer in the Order of Australia in June 2014 for distinguished service to medical administration through leadership roles with cancer control organisations and to the promotion of innovative cancer care.
This is an incredibly exciting time in oncology. New treatments and technologies are allowing us to cure patients we never thought we’d be able to cure. Vaccination and screening advances mean that we’re starting to see an actual decrease in the incidence of some cancers in high income countries. But not everyone is benefitting the same. Some people are being left behind both within countries and among countries. As an oncologist who is also involved in national policy development and implementation, I find UICC’s mission to advocate for initiatives that will decrease the global burden of cancer personally compelling. I want to channel my abilities into helping UICC set its strategic directions and realize this mission. Through exchange of knowledge and experiences with international colleagues I hope to strengthen the ties between Canada and the international oncology community. The world needs a strong and effective UICC. I would like to help with that.
I am a practicing medical oncologist, a health services researcher, and Vice-President of Cancer Control at the Canadian Partnership Against Cancer (CPAC). CPAC, like UICC, engages with and convenes a wide range of partners to accelerate and drive excellence in cancer care delivery, with a large focus on equity. This work requires skills in engaging patients, health ministries, experts, and cancer control leaders, along with deep knowledge and expertise in cancer control. Similar skills are needed within the UICC. In addition, my career has been split between Canada’s public health care system and the largely private one in the United States. Consequently, I will bring to the Board important insights and a unique perspective as a clinician, researcher, and systems-level thinker. I have held executive-level positions with Cancer Care Ontario and the Ontario Institute for Cancer Research over the past 10 years, and I have prior relevant governance experience, having served on the Board of Directors of the Canadian Breast Cancer Foundation, BioCanRx (a public-private partnership developing immunotherapies), and of the Canadian Cancer Research Alliance. I believe that my background can be put to good service as a Board member, continuing to move UICC forward in its quest to decrease the global burden of cancer.
I am heavily involved in national, regional and international cancer awareness, prevention, early detection, management & support of cancer patients & survivors, professional education, policy making, and promoting cancer control in Lebanon, Arab Countries and worldwide. My clinical, research, professional and public service experience with over 120 publications and books, hundreds of public appearances on cancer epidemiology, prevention and management would be at service of UICC and global efforts to curb global cancer burden, reduce disparities in outcome, and improve survival & quality of life worldwide, and advance UICC vision, innovate cancer control in High and LMIC, large cities, rural areas, as well as underserved populations in HIC, intensifying fight against cigarette & hookah smoking amongst young people worldwide, improve promotion and access to HPV & HBV vaccinations, screening and early detection, fight myths and misconceptions about cancer, improve data collection and registries, reduce disparities in access to diagnosis & care, make surgery, radiation and making new effective medications available & more accessible, pain control, advocate for patients’ rights and survivors, improving education & training, working with policy makers, medical centers, universities, public figures and philanthropic leaders, investment in health infrastructure, international collaboration, better transfer of knowledge and experience, and implementation of recommendations worldwide.
My personal education, training, knowledge, experience & leadership roles. As in my CV, I grew up in Beirut, graduated from Brussels, trained in New York, practiced in New York, Riyadh, Detroit and now Beirut. I am Founding President of Lebanese Society of Medical Oncology (LSMO), chaired ASCO International Committee, co-Chaired ASCO Guidelines Advisory Group for Resource-Stratified Guidelines, serve as member of several ASCO, ESMO, UICC, WHO, ESO Committees, co-author of ESO/ESMO ABC International Consensus Guidelines for Advanced Breast Cancer, ESMO/ASCO Global Curriculum for Medical Oncology Training, BHGI Guidelines, launched ASCO Resource-Stratified Guidelines, was nominated for ASCO Board of Directors, Lebanese Breast Cancer Committee Ministry of Health, President Lebanese Breast Cancer Foundation, Board member Arab American Medical Association, UICC SPARC Metastatic Breast Cancer Challenge Grants, UICC Essential Medications List & Book Chapter on Metastatic Breast Cancer, February 4th World Cancer Day activities, WHO Task Forces & Committee meetings in Cairo & Geneva. My research, teaching, patient care, advocacy, professional and community activities are recognised to have led to significant regional & international impact & downstaging of breast cancer in Lebanon & improvement of patient outcome for which I received Medals of Honor from the Presidents of Lebanon, League of Lebanese Woman’s Rights, Cairo University, Fellowship of ASCO Award 2018 & others.
In the past 30 years, the world cancer incidence has been increasing at the rate of annual average of 3%-5%. Especially in China, cancer has been accounted for more than 20% of overall deaths and about 4 million people are diagnosed with cancer in 2015.
As we all know, UICC is the leading cancer NGO in the worldwide. It has strong mission which is dedicated to unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda. The World Cancer Declaration launched by UICC has become the strategic plan for global cancer control which provides the direction and guideline to cancer societies from all over the world.
Facing to the challenge of global cancer burden, I, Daiming Fan, as the President of CACA, the Academician member and Vice President of Chinese Academy of Engineering, Vice President of Asian Pacific Association of Gastroenterology, and the Executive Board Member of Asia Oncology Society, have the responsibility to make efforts to promote cancer control not only in China, but also in the world. I do hope I could play a more critical role in spreading UICC ideal, taking action on cancer prevention and control, and to reach the goal of reducing cancer incidence and mortality rates in China through working along with UICC.
As the candidate of UICC Board of Directors, I am passionate for contributing myself to realise the vision of UICC. I am not only an oncologist, but also a gastroenterologist. My research concentrates on GI tract including gastrointestinal cancers, colon and other diseases. I am not only a clinician, but also a basic research scientist. Since 1989, I have published over 600 international journal articles and 24 books, and obtained 56 international and domestic invention patents. I am not only the leader in scientific research institutes, but I am also taking the leaderships in Chinese government, such as the VP of Chinese Academy of Engineering and the Committee Member of the National People’s Congress of China.
Last July, I was elected to be the President of CACA. CACA is a leading cancer NGO in China. During my presidency, CACA rapidly expands its network with individual members increased from 50,000 to 150,000, 16 new professional societies set up. There are 31 local anti-cancer associations across China. In 2018, CACA establishes branches in U.S., Australia, and Hong Kong and Macao area respectively. UICC China spoke is located in CACA.
CACA attaches high importance to seeking for business partnerships to improve capacity building, and has obtained sufficient financial supports. CACA is turning to be the most influential cancer NGO both in China and the world. If I join in the Board, I will devote myself and be faithful to be the board member of UICC.
I must say this was a challenge I haven’t thought about until I was asked if I wanted to proceed. But having in mind my personal history and my professional career, “yes” was the only possible answer. I’m a psychologist and I work in the Portuguese League Against Cancer since 1999. The truth is that when I started to work I didn’t knew a lot about “cancer”, “risk factors” or “prevention”. It was my first and only job and I have invested a lot in order to achieve the knowledge and the skills needed to work with all the target groups (from kindergarten till seniority) and in several contexts (in spite of the fact that schools were and still are our main field of work). I coordinate the health education department in the north of Portugal and since 2016 I’m the national coordinator as well. In fact, throughout the years, one of the tasks I was asked for was representing my institution at national and European levels (in ENYPAT –European Network of Young People and Tobacco – or ECL – European Cancer Leagues, for instance) and in several areas such as tobacco, breast cancer, sun prevention or HPV. As a result, in the last 20 years I achieved more knowledge, not only about cancer and risk factors or about people and their beliefs and perceptions, but above all about institutions and the power of networking. And this is why I think that belonging to the UICC Board of Directors is a meaningful challenge: it allows working together in a worldwide dimension in order to fight cancer.
In the last year I was invited to integrate the World Cancer Day Advisory Board, what was simultaneously an honour and an opportunity. It was my first experience in a worldwide network and it allowed me to understand as different countries and cultures see cancer and cancer fight. Nevertheless it was also a reality that all of us agreed that, in order to succeed, we must be creative and innovative. I think I have these characteristics besides the fact I don't fear to work and apply myself on each task I'm assigned.
For the last 20 years I have been working in a national and European level, representing my institution and my country on network meetings, conferences, task forces, etc. And in 2017 I was the leader of the organising committee of ECTOH – European Conference on Tobacco or Health.
Portugal is a small country comparing to others but we do a lot of work in cancer prevention: we were one of the countries with more activities on the World Cancer Day Map of Impact… and we do cancer prevention activities all the year and not only on the 4th of February. We are always trying to innovate and I think I would be able to represent the culture of the Mediterranean countries and, of course, the more than 220 million Portuguese speaking worldwide. Also, I guess it could be helpful that I speak English fluently but also French, Spanish and even understand a little bit of German.
New York, United States
I strongly believe in the vision and mission of UICC. UICC is unparalleled as a truly global civil society organisation dedicated to improving access to cancer care and control for all. UICC is unique in its capacity to unite the cancer community in these efforts, comprising a diverse membership and a community of advocates not limited to any region, country income level, or discipline. Its growing influence is helping to integrate cancer control into the global health and development agenda. While I was a Medical Officer at WHO I worked closely with UICC in joint advocacy efforts, including the development of the 2017 Cancer Resolution. At the 2016 World Cancer Congress we launched The Lancet Series: "Health, equity, and women's cancers" with more than 40 authors from 18 countries. In Kuala Lumpur this October I greatly look forward to joining colleagues from all over the world and will serve as chair or speaker in four WCC 2018 sessions including those organised by IARC and the U.S. NCI Center for Global Health. I enjoy serving as an expert advisor to regional and global UICC campaigns and events including the new "Treatment for All Campaign". In May 2018 I spoke on behalf of UICC at a United Nations member states briefing to prepare for the next High-Level Meeting on NCDs at the 2018 UN General Assembly. I wish to serve on the UICC Board of Directors to dedicate more time and effort in pursing our common mission, to reduce the burden and impact of cancer globally.
I am a medical oncologist with expertise in cancer prevention, early detection, and global public health. I have dedicated much of the last 15 years to global cancer control research, education, and policy, working with colleagues on five continents. I am advisor to Vietnam's National Institute for Cancer Control and an adjunct faculty member at BRAC University's School of Public Health in Bangladesh. In 2015-2016 I was a Medical Officer at WHO, where I provided assistance to member states and represented the agency on the Secretariat for the UN Joint Programme for Cervical Cancer Prevention and Control. Now based at New York University as Director of Cancer Genetics and Associate Professor of Population Health and Medicine, I continue to work with WHO, IARC, and IAEA, and have recently participated on missions to Sudan, Indonesia, and Myanmar. Just prior to the 2018 World Health Assembly, I spoke at the Third Annual Ministerial Roundtable, "Cervical Cancer: and NCD we can overcome" with leadership from UICC, World Bank, U.S. NCI, GAVI, and the Global Fund. I am very active on social media and use these platforms to promote the work of UICC in cancer advocacy efforts. I believe I have a unique combination of skills and experience to serve the mission of UICC. I am passionate about making substantive contributions to the organisation, and if I am fortunate enough to be elected I will be a highly engaged and effective member of the UICC Board of Directors.
Seattle, United States
I am committed to improving cancer outcomes at a global level. Throughout my oncology career I have supported cancer patient advocacy, creating opportunities for partnerships between patients, health care providers, and policy-makers. I have led international efforts in cancer education, advocacy and outreach, founding the Women's Empowerment Cancer Advocacy Network (WE CAN) to further this mission. I have promoted health professional training and capacity-building, serving as a senior advisory member of the Uganda Cancer Institute Hematology-Oncology Fellowship program. I am committed to improving the quality of life of cancer patients through healthy lifestyles, founding Team Survivor Northwest, a non-profit aimed at helping female cancer survivors improve their health through fitness and exercise. I regularly participate in UICC World Cancer Congresses and World Cancer Day activities, and am aware of the important role UICC plays on the global stage. I have served as a collaborator and mentor for UICC SPARC grant recipients, and helped create a UICC Master Course in metastatic breast cancer. My passion for empowering patient advocates is in excellent alignment with UICC’s mission. My strong relationships within the global oncology community and my expertise in cancer care and clinical trials can serve as assets to UICC. I believe that serving on the UICC Board of Directors would allow me to contribute on an even larger scale to improving cancer outcomes globally.
I am Professor of Medical Oncology/Global Health at the University of Washington and Fred Hutchinson Cancer Research Center, with a commitment to empowering patient advocates and addressing health disparities. I have diverse experience in global oncology that could provide expertise to UICC. I work closely with patient advocates through the Women’s Empowerment Cancer Advocacy Network and serve in professional advisory capacity for cancer advocacy NGOs across the world. I have on-the-ground experience with cancer care in limited resource settings as a member of the Fred Hutch-Uganda Cancer Institute collaboration. As an expert in cancer clinical research, I am a strong advocate for evidence and innovation in improving cancer diagnosis and treatment. As a member of the Global Task Force on Expanded Access to Cancer Care and Control, I gained perspective on the roles of health systems and health policy in cancer control. Through volunteer activities in oncology professional societies, I have forged relationships with colleagues across the globe. I chair ASCO’s Academic Global Oncology Task Force, served on ASCO’s International Affairs Committee, and am co-chair of ASCO’s Resource Stratified Guideline Group. I have experience coordinating summits, gaining consensus, and leading global campaigns, co-chairing Breast Health Global Initiative resource-stratified guideline summits, and Breast Cancer Initiative 2.5 - a global campaign to reduce disparities in breast cancer outcomes.
London, United Kingdom
Cancer is now recognised as a global health and development priority. The coming years bring an enormous opportunity for us to make progress globally, leveraging new funding and partners around the world. They also bring a drive towards greater alignment in the global fight against cancer, to more collaboration and partnership, and to a greater focus on equity. Working for a large cancer society like Cancer Research UK, I am passionate about how the global cancer community can collaborate more closely, learn from each other and build common approaches to tackle the disease globally, as well as tackling the specific issues in our own countries.
I have served as a member of the UICC Board for the last two years, playing an active role in both the Board and a number of sub-committees and played an active role in the World Cancer Leaders’ Summit and World Cancer Congress. I have been inspired by the work of the organisation and of its members, and by the desire to innovate and continue to grow the ambition. Being a member of the Board has helped me to join the dots between the work of my organisation and the global fight against cancer. I am passionate about finding new opportunities for collaboration and finding ways to bring together the exceptional talent and experience that exists in member organisations around the world.
As a current Board member, I would look to bring continuity in terms of Board involvement and in the implementation of both existing UICC plans and the new UICC strategy which will be shared at this Congress. In the last two years, in addition to contributing to the Board, I have contributed as a member of the Partnerships Committee, the Capacity Building Committee, and as part of the Strategy Task Force and McCabe Task Force.
My career has given me experience of commercial and non-profit organisations in a number of sectors, and in over 25 countries. I have worked in the International NGO sector, developing a new global governance model at Save the Children, and supporting local programmes in Colombia and the Philippines in particular. At Cancer Research UK, I have broad experience across fundraising, research funding, and policy, and have led our efforts to work more closely with other cancer societies in various parts of the world, leading to a number of tangible partnerships.
I believe passionately that UICC has an important role to play in convening cancer societies and other member organisations from around the world, and supporting us all in growing our impact. I am excited to take forward some of the exciting ideas in the new UICC strategy, particularly in working to deepen engagement between UICC and its members.
As a President of French African Pediatric Oncology Group (GFAOP), I have with my group contributed in building capacity and providing support to almost all French speaking African countries. We have also been able to put in place African School of Pediatric Oncology with the contribution of University Mohammed V in Rabat in Morocco and Paris-Sud in France. We are also putting in Place the Institute Jean Lemerle with University of Dakar. Beside this our group is contributing in providing medication and supplies for paediatric oncology paediatric pilot units. This experience that started since 2000, initiated by a French paediatric oncologist (Pr Jean Lemerle) is considered a success because of capacity of mobilisation and also because it integrated support, capacity building and clinical research and publications. More than 1000 new children are treated in the GFAOP network. In a continent with tremendous needs this maybe a model for development of cancer care in general. In my country I have also worked in developing care through a national paediatric cancer society with various adapted approaches. I have been participating as a Board member in UICC and have been able to contribute to its activity. I believe that UICC can contribute efficiently in limited resources and particularly in Africa.
UICC is recognised as a key actor in cancer control at a global level. It is now having more ambitious role in developing successful models. C-Can programme is one of the models that should make direct impact in cities in developing countries. In Africa, cancer care is not considered as priority by most African stakeholders. UICC may play efficient role in capacity building and gathering resources as it is already the case in particular in capacity building. Comprehensive approaches and developing networks are needed for more efficiency. The experience of GFAOP in putting in place childhood cancer care in French speaking African countries may help.
Cancer incidence rate is going to rise worldwide specially in developing countries. I have had the honour to serve a first term (2016-2018) as a member of the UICC Board of Directors. If I have the chance for a second term, I would continue to support and align with the current plans in achieving UICC objectives to reduce the global cancer burden, promote greater equity for every cancer patient to have a better medical care, and integrate cancer control into the world health agenda. This would be done through supporting ongoing activities related to city cancer challenge, basic and human capacity building, universal availability of effective pain medication, dispelling myths and misconceptions about cancer, and delivering the targets of the World Cancer Declaration.
Examples of my activities during the first term as UICC Board member expressing full engagement include active participation on the Membership Committee to support the ambition to grow and engage UICC membership, be part of the UICC strategic review process that sets the organisational ambitions for 2030, participation on key convening events such as World Cancer Day (by attending many national and regional events),World Cancer Leaders' Summit and World Cancer Congress, ensuring the voice of the region to be represented at the highest level at UICC, e.g. discussing the economic burden of new treatments on health systems, and getting more experience on how UICC is governed and working.
I am a professor of medical oncology at the National Cancer Institute, Cairo University. In 2002 I served as the dean of this comprehensive institute for six years. Thereafter, I was appointed Vice President of Cairo University (2008 – 2011) and then Minister of higher education of Egypt (2012). I have been engaged in many cancer control activities on a national level, such as secretary general of the Egyptian foundation for cancer research, head of the council of the Egyptian medical oncology fellowship, and the Editor-in-Chief of journal of advanced research (the official journal of Cairo University).
Regionally and internationally, I served as the Assistant Secretary General of the Arab Medical Association Against Cancer for four years, the national representative of ESMO for Egypt and North Africa (2000-2006), and I am also a member of many international societies including ESMO, ASCO, and the lymphoma group in the EORTC. I was also a member of the editorial board of the Annals of Oncology (2006-2012).
My research activities are focussed mainly on bladder cancer, breast cancer, and malignant lymphomas, with more than 150 national and international publications (total impact factor of 500; total citations of >3000, and h-index of 27 as of May, 2018).
Hong Kong S.A.R., China
As a clinical oncologist providing medical care to cancer patients, I witness the sufferings caused by cancer and strive to help patients to overcome this devastating disease. As an academic, I teach medical students how to become a good oncologist to provide holistic cancer care for patients and their families. As a cancer researcher, I explore for the most effective cancer treatment, yet there is still gross inequity to appropriate care. As a leading member of the HKACS, I promote cancer education both for the public and health care professionals, support cancer research, launch charity programs to assist patients with financial difficulty in getting new expensive cancer drugs, and advocate comprehensive cancer plan for our community. However, I keenly feel the inadequacy of impact by a single voice and local effort.
I strongly believe that concerted global advocacy is crucial for saving more lives and minimising sufferings. UICC is taking a leading role in the global fight against cancer and transforming global vision into actions. The unique network with leaders across the world provides an invaluable opportunity for raising global awareness on cancer burden and influencing policy making on sustainable comprehensive actions for reducing cancer mortality. Furthermore, the growing international network provides an excellent platform for sharing of experiences and engaging top international experts to help low-middle income countries.
Mexico City, Mexico
At the beginning of my career, as a researcher in cancer epidemiology in Mexico; later, as General Director of the Mexican National Cancer Institute where I promoted and encouraged the operation of public policies for cancer control - among others the Seguro Popular - for the prevention, diagnosis, treatment and palliative care for thousands of patients that arrived for medical care at this oncological center. Since 1997, I attended the UICC Congress and saw the commitment of this organisation in promoting, establishing and evaluating interventions worldwide. Particularly, in low and middle-income countries, where there are opportunities for a better cancer control.
During my 10 years as Director of the Mex-NCI, I realised that these opportunities can be reached with a more active, pro-positive, and passionate use of different instruments that today are available for the civil society, i.e. health education, primary prevention, and access to optimal medical care by the health systems in place. The governments have this responsibility; however, sometimes they forget it and is the role of organisations like UICC to remind them what should be their priorities.
Send a message to better define actions that could have an impact for communities in much need. For all these reasons It will be an honour to be member of this Board, and of this extraordinary commitment of UICC for each one of the cancer patients worldwide.
My background makes me a good candidate. I am Pathologist, and got a Doctoral degree in Epidemiology at the Harvard School of Public Health in 1990. After graduating I came back to my country, and since then I worked at the Mexican National Cancer Institute. I have done extensive research and public health interventions for a better control of cancer in Mexico, and multiple international collaborations within the network of Cancer Institutes in Latin America and the USA.
From 2003 to 2013, I was General Director of the Mex-NCI. During my tenure I collaborated with all national and several international organisations committed to cancer control. I learned from them the concept and value of advocacy, and understood that the best way to fight cancer is through a team effort. I also actively participate in the UICC-meetings worldwide, and identify opportunities for cancer control.
From November of 2013-2016, I was member of the International Narcotic Control Board of the United Nations. I learned the huge needs to access of palliative care worldwide. I worked to change this reality, and as member of the UICC-Board we could continue this effort.
Finally, I actively participated in the organisation and operation of the past UICC Congress that took place in Mexico City last November of 2016. For all these reasons, I strongly believe that there is every reason to believe that I am a competitive candidate to be elected as Member of the Board of Directors.
Rio de Janeiro, Brazil
As the Director General of the Brazilian National Cancer Institute for the past two years, I have been able to contribute to increase the quality of care services, research projects and public policies advanced by the Institute, by evoking international collaboration as the means to advance the Institution’s reach and scope of action. In this approach, we have strengthened ties in South-South Cooperation both with Latin America and with Portuguese Speaking Countries in Africa, reinforcing the Brazilian commitment towards the 2030 Agenda for SDGs in regard to the NCDs targets. Such actions are aligned to the global effort called upon by the 2017 WHO Resolution on Cancer Prevention and Control in the context of an integrated approach. I have been able to further develop my management and leadership skills by facing the great challenge to lead the technical branch of the Ministry of Health working on Cancer Prevention and Control in one of the world's biggest public health system. As INCA’s representative I have participated in numerous international fora and decision-taking instances discussing global health and cancer control and ways to enhance global partnerships towards this goal. At UICC, I have participated in the 2017 World Cancer Leader’s Summit and in the first Latin American meeting of the C/Can 2025 initiative, as a health sector expert discussing new financing possibilities and sustainable solutions for the treatment of cancer in the challenge cities.
Firstly, I believe my experience having acted in different contexts, ranging from care to management, from the general health to the broad cancer context, is certainly an asset to contribute to my role in the Board of Directors. I have over 25 years of experience in cancer care and management, including research and teaching positions. I hold a Bachelor Degree in Medicine and specialisations in Anesthesiology and Innovative Leadership in Health. I have been responsible for the Medical Residency Program in Anesthesiology at INCA and I have been President of the Rio de Janeiro Society of Anesthesiology, which gave me opportunities to improve my management and leadership skills. I have also developed extensive research on Preoperative anesthesia, Opioid free anesthesia, Multimodal opioid free anesthesia, Pain Management, Immunology and Surgical Oncology. Moreover, I have broad experience both in private and public health systems, with several international collaborations in Latin America, targeting the improvement of health management and Health Care innovation. I believe such partnerships have given me expertise to stimulate greater collaboration among Board members and to contribute to intercontinental cooperation with UICC members and stakeholders, in order to deal with the global cancer burden.
UICC is a unifying force that has made cancer control prominent on the world health and development agenda through its diverse membership and unwavering commitment to improving cancer control. I am motivated to serve on its Board of Directors because of my strong belief in its mission to reduce cancer disparities and to improve the lives of cancer patients everywhere. Serving on the Board would be a unique opportunity to work with its dynamic members to enhance the impact of UICC and to engage future generations of cancer leaders, who can become a community of ambassadors for UICC and extend its strong voice on the global stage.
Through my roles as a cancer physician, health policy researcher, and global health advocate, I understand that multiple approaches are needed to advance cancer control. I twice received the UICC Young Leader award and have strong technical expertise in global health, health economics, and community activism, all of which can be directed to advance UICC’s strategic goals. Through my work, I also have close collaborative relationships with members from countries around the world. As UICC continues its role as a world leader in cancer control and grows as an organisation, these collaborative relationships, together with my skill set, experience, and shared vision, would allow me to make a valuable contribution. It would be a great honour to contribute to the mission of the UICC and to work with the outstanding leaders on its Board of Directors.
My experience in clinical practice, health policy, research, and in large international initiatives make me a strong candidate for the Board of Directors. Princess Margaret Cancer Centre, where I work, has a longstanding commitment to UICC and I have been personally engaged in its Congresses and Leaders’ Summits. I led the economic analysis for the UICC/Lancet Oncology Global Task Force on Radiotherapy for Cancer Control and, while on that Task Force, built the GlobalRT advocacy movement for radiotherapy, which mobilised professionals from around the world to raise awareness about disparities in access to radiotherapy through films, blogs, and other multimedia– all essential tools to promote UICC’s important work.
As a practicing cancer physician, I understand the frontline challenges in cancer control and, as a health policy researcher, I appreciate the evidence that is needed to engage health systems in capacity-building partnerships. My research is focussed on the economics of cancer and on improving access to care across all resource settings. This work has been recognised through invitations to work with the World Health Organization and the International Atomic Energy Agency, and has generated ongoing international collaborative relationships. I would bring these experiences in advocacy, policy, and global health to the UICC Board of Directors, along with the perspective of the new generation of leaders and a deep personal and professional commitment to cancer control.
Birnin Kebbi, Nigeria
Understandably, due to a high burden of infectious disease with limited resources, the political will to mainstream cancer control into the health agenda of LMICs is poor. However, the political privileges of being the wife of a governor, combined with my professional career as a physician and passionate cancer advocate has enabled me to demonstrate that cancer can be comfortably accommodated in our health agenda.
Membership of the UICC board will provide me with a unique platform to harness global opportunities to build local capacities to combat cancer not only in Nigeria, but in Africa. Using experiences garnered from grassroots mobilisation for cancer control in my community, I can positively impact implementation of global commitments towards achieving the goal of 25% reduction in Non-Communicable Diseases (NCD) premature deaths by 2025.
For UICC to meet its goal of uniting the cancer community to reduce global burden of cancer, deliberate attention is required in Low and Middle-Income Countries (LMIC) where I operate and where the burden of the disease is highest.
I have been working in the cancer control space for more than 10 years in Nigeria and have been exposed to both international and national cancer fora. I set up the Medicaid cancer Foundation [MCF], as a non-profit body dedicated to improving the quality of life of cancer patients by providing treatment support and reducing the burden of cancer.
MCF organises many innovative fundraising and awareness events round the year including World Cancer Cay activities. This includes the now famous annual Cancer Awareness walk. We have built human capacity building for screening of common cancers by training nurses in 24 Local Government areas in Kebbi State. In 2017, MCF initiated summits to strengthen cancer registration in Nigeria in 2017. Currently we are supporting the development of a cancer control plan for Kebbi State and a population cancer registry in the state. All these activities are personally supervised by me as Chair of MCF.
At national level, I served in a ministerial committee to upgrade cancer treatment facilities and I am currently advocating for a presidential task force for improving national cancer control.
I have collaborated with international organisations such as Gavi, West African Division of the International Academy of Pathology and the Cherie Blair Foundation.
The foregoing experiences over a lengthy period, will assist my contribution to achieve the objectives of the UICC, and makes me a good candidate to serve on its Board.
Having more than 30 years’ experience in cancer control at local state national and international level I would like to offer my expertise to the strategic decision making body for UICC.
Joining the Board is an opportunity for me to improve international efforts on mission and achieving the greatest possible progress in cancer control, with a particular focus on achieving progress in low and middle-income countries. Enormous opportunities in prevention and early detection of cancer and all NCDs exist, particularly now with developments in the international arena in NCD prevention, if existing learnings are applied internationally.
As a current Board member of a Health Promotion agency and CEO of a national organisation focussed on public health, along with governance training through the Australian Institute of Company Directors, and 24 years working in a Cancer Control organisation, I can bring an important range of experience to the deliberations of the UICC Board.
I also hold Adjunct Professorial appointments at two universities and have research experience which will assist in contributing to evidence based decision making at board level.
I believe Board leadership should come from a close understanding of the mission of the agency. I am confident I can bring that to a leadership role at UICC and would welcome the chance to serve this vital international effort.
Adjunct Professor Terry Slevin has been involved with UICC for more than a decade contributing to planning for the past four World Cancer Congresses.
He has served as Co-Chair of the Scientific Program Committee for WCC 2018.
He led the creation of the 2009 World Cancer Day Report on childhood obesity and have contributed to workshops and capacity building within the cancer control community for more than 2 decades. He has advised UICC on issues such as obesity, alcohol and asbestos.
He has leadership credentials in cancer and non cancer organisations, governance training, international cancer control expertise across a range of issues from tobacco, skin cancer, nutrition, obesity, screening and advocacy.
Terry is passionate about sharing expertise and ensuring knowledge transfer to maximise efficiency in investment of cancer control resources to ensure the best outcomes. He has a long history of successful financial and people management and has built up strong networks internationally in cancer control.
He has supported the development and training of cancer control young professionals and focussed on supporting low and middle-income countries best develop and advance cancer control policy and practice.
Most importantly Terry is committed to the success and ambitions of UICC as a world leader in cancer control.
And as you can see from the photo, he likes to laugh.
Kuala Lumpur, Malaysia
Every problem, even one as big and complex as cancer, is an opportunity.
While gravely concerned about the rising global cancer burden, as the President of the National Cancer Society of Malaysia (NCSM), I am also excited about the chance to halt the deluge.
About 20 years ago, I started at NCSM as the clinician. As the focus of cancer control – especially in Asia – shifted from treatment, to support, to early detection and prevention, I’ve led NCSM to expand, adapt, and drive these initiatives.
We’ve since battled for better cancer care, early detection of breast cancer, vaccination and prevention of cervical cancer, and stronger tobacco control.
NCSM has thus evolved from a medical-centric organisation to one that leads awareness and behavioural shift programmes, advocates for policy change, urges regular surveillance, and complements the work of governments and NGOs. Today, we lead and inspire the fight for cancer control in Malaysia.
Most importantly: we unite and empower LMICs in cancer control. Today, with cancer being on the global agenda, and with strategies that are aligned with the SDGs, it is the golden hour to further our reach, bridge the gaps, and strengthen countries that are affected the most.
Our hosting of the World Cancer Congress in Kuala Lumpur this year will enable us to build on the work we have started nationally and regionally. It gives me no bigger honour than contributing to the platform from which NCSM has benefited the most – UICC.
Having been on the Board of UICC for two terms, I now Chair the Membership – and am a member of the Capacity Building – committee. In the latter positions, I prompted greater investment into engagement and capacity building of UICC members and countries in need.
I am committed in ensuring a continuous enhancement of member benefits that reflect changing requirements. I’m also dedicated to the development of programmes that empower organisations to enact change.
In my tenure as President, the National Cancer Society of Malaysia (NCSM) has created greater visibility of UICC within the region via new and existing networks. Championing for the interest of low resource countries through these excellent relationships have resulted in a higher commitment in capacity building and in cancer control.
I hold positions at the Malaysian Council for Tobacco Control, chair NCD Malaysia, and am on the Boards of International Cancer Information Service (ICISG) and ASEAN NCD Alliance.
My experience in the medical, advocacy, policy, operations and public health aspect of cancer provides me a comprehensive picture of the benefits, challenges, needs and gaps of cancer control in ASEAN.
This, along with my ongoing initiatives, passion, and drive, continue to broaden my vision of how we can minimise the threat of cancer. I believe that sharing – as well as learning – from the UICC Board will help widen it.
Cape Town, South Africa
As a cancer survivor and a committed volunteer, working both locally and internationally on various cancer forums, I have been exposed to grass roots realities that affect cancer patients.
I was instrumental in training Reach to Recovery groups in 14 African countries. These groups today support cancer patients, run educational outreach programmes, and advocate for suitable health policies in their countries.
I was invited to serve on the support task team of the Breast Health Global Initiative that developed policy guidelines for the management of breast cancer in low and middle income countries.
As President of Reach to Recovery I led the team that organised the successful RRI Conference in Cape Town 2013.
As a member of the Cancer Alliance we have advocated government successfully to make cancer a National Priority, to develop a National Cancer Control Plan and to improve Cancer Registries and Data. At present we are advocating for Patent Law Reform:- "patent ever greening" sees thousands of patients die because they are unable to afford the life saving medicines.
As a cancer survivor it would be a privilege to be able to represent the thousands of cancer patients whose voices are not often heard on international boards.
Should I be re-elected as a UICC Board member I would be able to ensure their needs are always part of the global focus of the UICC. It is for this reason and those above that I would like to serve on the UICC Board.
I would like to be on the UICC Board of directors because I think that with my experience I can contribute to promote cancer control among countries, to promote the implementation of strategies for cancer prevention, early detection, to reduce inequities to cancer treatment technologies and to promote access to palliative care.
As long as I participated in the initiative of the UICC C / Can 2025, specifically in the implementation of the process in Cali, I would like to contribute and participating with other countries.
I have 20 years of experience in national and international activities for cancer control. As a researcher and as a public health worker I mainly contributed with the tobacco control and with the evaluation and implementation of cervical cancer strategies such as screening and vaccination programs.
I have been the General Director of the National Cancer Institute of Colombia, one of the oldest National Cancer Institutes in Latin America for almost 4 years. I worked, in coordination with the Ministry of Health promoting comprehensive cancer control. I also participated in the formulation and monitoring of the National Cancer Plan of Colombia 2012-2022.
My relationships with key international agencies such as WHO/PAHO, IARC and networks as RINC, can be a key factor in order to contribute to UICC objectives.
The incidence of cancer is increasing globally and WHO predictions are of a rapidly changing landscape with a projection that two thirds of cases will be from the developing world within the next two decades. The problem is further compounded by the fact that of the premature cancer deaths worldwide, two thirds occur in low- and middle-income countries (LMICs), the majority of which lack proper infrastructure and resources.
There is therefore a well-recognised need for action and promoting greater equity in these resource-limited settings.
Much also needs to be done in the developed world where numerous issues hamper the progress in cancer control. These range from rising cost of cancer care, geographic distribution of service issues, socioeconomic inequalities, in addition to the growing epidemic of obesity as a major cause for cancer. Other global issues to be addressed are the implementation of HPV and HBV vaccinations, cancer drug pricing, availability of healthcare, human resources and healthcare systems infrastructure.
Civil society must engage in addressing these issues.
UICC is the ideal organisation to convene the voice of civil society with its membership including diverse groups of organisations with a reach of over 150 countries. In addition, UICC has strategic alliances with other major stakeholders, namely the NCD Alliance, WHO, IARC and IAEA, which help integrate cancer control into the world health and developmental agenda.
The expansive reach, the impact and the great potential of UICC has been more apparent over the last six years, and as a member of the Board of Directors, I had many opportunities to witness the impact that our organisation has on global cancer control and to contribute to the development of the strategy and long-term goals for UICC. Being an integral part of two strategy planning meetings of the UICC has helped me contribute to the road map that the organisation will take over the next decade. As President, I will therefore be ideally suited to shape this vision and contribute along with the Board of Directors and the Geneva team towards this effort.
Personally, I have been engaged in the cause of cancer control at the national level in India as an oncologist, researcher and administrator and globally as a leader in head and neck cancers. These multiple roles place me at an advantage in understanding the intricacies of the problem, a profound understanding of the role that research science must play in cancer control, identify priority areas that need attention and the potential solutions that need to be worked on.
Having the opportunity to lead UICC will help consolidate my current efforts as well as give new direction towards reducing the cancer burden globally.
Lastly, it is time for the leadership of UICC to come from the area with the largest population and largest cancer burden, where the majority of the World Cancer Declaration targets need to be addressed. In addition, encouragement from the majority of member organisations and global leaders in cancer control motivates me to resubmit my nomination yet again.
I have been actively involved and possess a strong knowledge of the working and the mission of UICC having served on the Board of Directors for the last four years. The purpose statement of UICC was drafted during this time and I was actively involved in this process.
I have also served on many of the pivotal committees of the Board, namely the Governance, Finance, Membership, Congress and World Cancer Leaders’ Summit. I have had the privilege to lead the Paris 2016 World Cancer Congress as well as the 2018 Kuala Lumpur Congress as co-chair. In addition, I have been editor of the recently published UICC Manual of Clinical Oncology as well as serve as a member of the literature watch committee of the UICC TNM.
With thirty years’ experience as an oncologist, researcher and administrator in the field of cancer control, I have been Director at Tata Memorial Hospital in Mumbai, India – the largest and one of the oldest comprehensive cancer centres. The hospital is considered a leader not only in the country, but also in the region for cancer control activities and policy. It has had a close association with UICC since its inception and hosted the UICC World Congress in 1994.
I hold numerous leadership positions both nationally and internationally on board of directors, governing councils and executive committees of various hospitals, research centres, governmental organisations, cancer care organisations, advocacy group and professional bodies.
Having delivered over 350 lectures, keynote addresses and orations around the world, I am comfortable speaking and interacting at the highest levels. I have a strong scientific background, having authored over 200 peer-reviewed publications. This unique position of being a clinician, researcher, administrator and a leader gives me the advantage of bringing the right blend of science and action into the fight on cancer control.
The prime area of my focus would be towards consolidating efforts to achieve the World Cancer Declaration targets.
Top of the list of priorities would be – tobacco control advocacy which still is a major issue worldwide, more so in LMICs. In addition, efforts towards control of cervical cancer responding to the recent call of the WHO director general would be high on my agenda.
I would make efforts to unite the cancer community by enrolling more members as well as ensuring that current members are more engaged in the activities of UICC. Efforts will be made to broaden our relationships with other cancer and non-cancer related partners. I also believe that engaging potential young leaders would be the right step towards ensuring the continuity of cancer control in the years to come.
I will strive to put objective criteria in monitoring our progress towards the implementation of the World Cancer Declaration targets. In addition, as part of this effort, I shall try to develop implementation tools that are adaptable at different levels and across different regions of the world.
As part of the ‘C/Can 2025’ Task Force, I will build and take this latest initiative to completion. C/Can 2025 is a new initiative of UICC, focussed on putting together a total cancer solution for cities globally. Initially targeted at five cities, the final plan is to impact 500 cities worldwide. There is so much to do, but space constraints restrict me from listing all. Let’s walk together to make a difference in our efforts towards global cancer control.
The information contained in each of the candidates' profile has been provided by the candidates themselves, and it is intended exclusively for the UICC members voting at the elections for the UICC Board of Directors and President-elect. UICC's role is limited to providing the platform for the candidates to share their information and views. The views expressed by the candidates are not those of UICC. Any use, disclosure or unauthorised reproduction of this information is prohibited.